Oncternal Therapeutics Inc
(ONCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,511 | 14,958 | 15,816 | 53,431 | 5,156 |
| Marketable Securities | 29,205 | 17,186 | 28,083 | 200 | 6,200 |
| TOTAL | $47,580 | $34,211 | $46,077 | $55,680 | $13,486 |
| Non-Current Assets | |||||
| PPE Net | 35 | 43 | 51 | 57 | 65 |
| Intangibles | 101 | 105 | 108 | 112 | 116 |
| TOTAL | $136 | $148 | $159 | $169 | $181 |
| Total Assets | $47,716 | $34,359 | $46,236 | $55,849 | $13,667 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,473 | 1,739 | 2,604 | 2,451 | 603 |
| Accrued Expenses | 6,404 | 7,871 | 5,371 | 6,828 | 4,582 |
| TOTAL | $7,877 | $9,610 | $7,975 | $9,279 | $5,185 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $7,877 | $9,610 | $7,975 | $9,279 | $5,185 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 172 | 161 | 156 | 154 | 115 |
| Common Shares | 24 | 23 | 22 | 22 | 16 |
| Retained earnings | -585,209 | -575,194 | -561,637 | -552,360 | -543,856 |
| TOTAL | $39,839 | $24,749 | $38,261 | $46,570 | $8,482 |
| Total Liabilities And Equity | $47,716 | $34,359 | $46,236 | $55,849 | $13,667 |